CC BY-NC-ND 4.0 · Aorta (Stamford)
DOI: 10.1055/s-0044-1779250
Case Report

Ruptured Mycotic Thoracic Aortic Aneurysm in the Setting of Streptococcus Bacteremia with Underlying Colonic Malignancy

1   Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN
,
Bernardo C. Mendes
1   Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN
› Author Affiliations
Funding None.

Abstract

Ruptured mycotic thoracic aortic aneurysms (TAAs) pose complex clinical challenges which are often compounded by existing comorbidities of the typical patient. We present the case of an 85-year-old female presenting emergently with a ruptured mycotic TAA with underlying Streptococcus bacteremia who was successfully treated with a thoracic endograft and antibiotics.



Publication History

Received: 18 December 2022

Accepted: 13 December 2023

Article published online:
20 March 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Wilson WR, Bower TC, Creager MA. et al; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; Council on Peripheral Vascular Disease; and Stroke Council. Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the American Heart Association. Circulation 2016; 134 (20) e412-e460
  • 2 Sörelius K, Mani K, Björck M. et al; European MAA collaborators. Endovascular treatment of mycotic aortic aneurysms: a European multicenter study. Circulation 2014; 130 (24) 2136-2142
  • 3 Sörelius K, Wanhainen A, Wahlgren C-M. et al. Nationwide study on treatment of mycotic thoracic aortic aneurysms. Eur J Vasc Endovasc Surg 2019; 57 (02) 239-246
  • 4 Jonker FHW, Verhagen HJM, Lin PH. et al. Open surgery versus endovascular repair of ruptured thoracic aortic aneurysms. J Vasc Surg 2011; 53 (05) 1210-1216
  • 5 Goodney PP, Travis L, Lucas FL. et al. Survival after open versus endovascular thoracic aortic aneurysm repair in an observational study of the Medicare population. Circulation 2011; 124 (24) 2661-2669
  • 6 Escobar GA, Eliason JL, Hurie J, Arya S, Rectenwald JE, Coleman DM. Rifampin soaking Dacron-based endografts for implantation in infected aortic aneurysms–new application of a time-tested principle. Ann Vasc Surg 2014; 28 (03) 744-748
  • 7 Sörelius K, Wanhainen A, Furebring M, Mani K. Swedish Collaborator Group for Infective Native Aortic Aneurysms. The microbiology of infective native aortic aneurysms in a population-based setting. Ann Vasc Surg 2022; 78: 112-122
  • 8 Reynolds JG, Silva E, McCormack WM. Association of Streptococcus bovis bacteremia with bowel disease. J Clin Microbiol 1983; 17 (04) 696-697